Align Technology (ALGN) Cash from Financing Activities (2009 - 2026)
Align Technology (ALGN) posted quarterly Cash from Financing Activities of -$48.1 million for Q1 2026, up 76.72% year-over-year from -$27.2 million in Q1 2025, and up 50.59% quarter-over-quarter from -$97.4 million in Q4 2025.
Align Technology (ALGN) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Align Technology (ALGN) has reported Cash from Financing Activities for 18 consecutive years, with -$48.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 76.72% year-over-year to -$48.1 million; the TTM figure through Mar 2026 stood at -$306.0 million (up 44.45% YoY), while the FY2025 annual figure was -$464.6 million, down 30.6% from the prior year.
- Cash from Financing Activities grew to -$48.1 million in Q1 2026 per ALGN's latest filing, from -$97.4 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $11.8 million in Q3 2023 and bottomed at -$350.3 million in Q4 2023.
- Historically, Cash from Financing Activities has averaged -$115.8 million across 5 years, with a median of -$97.4 million in 2025.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities soared 116.77% — and 2024, when it slumped 16179.16%.
- Align Technology's Cash from Financing Activities stood at -$200.2 million in 2022, then tumbled by 74.98% to -$350.3 million in 2023, then surged by 42.04% to -$203.0 million in 2024, then soared by 52.02% to -$97.4 million in 2025, then surged by 50.59% to -$48.1 million in 2026.
- Business Quant data shows ALGN's Cash from Financing Activities at -$48.1 million in Q1 2026, -$97.4 million in Q4 2025, and -$64.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | -67.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -67.45 Mn |
| Jun 30, 2026 | -67.45 Mn |
| Mar 31, 2026 | -48.13 Mn |
| Mar 31, 2026 | -48.13 Mn |
| Dec 31, 2025 | -97.41 Mn |
| Dec 31, 2025 | -97.41 Mn |
| Sep 30, 2025 | -64.12 Mn |
| Sep 30, 2025 | -64.12 Mn |
| Jun 30, 2025 | -96.30 Mn |
| Jun 30, 2025 | -96.30 Mn |
| Mar 31, 2025 | -206.76 Mn |
| Mar 31, 2025 | -206.76 Mn |
| Dec 31, 2024 | -203.02 Mn |
| Dec 31, 2024 | -203.02 Mn |
| Sep 30, 2024 | 10.57 Mn |
| Sep 30, 2024 | 10.57 Mn |
| Jun 30, 2024 | -151.56 Mn |
| Jun 30, 2024 | -151.56 Mn |
| Mar 31, 2024 | -11.72 Mn |
| Mar 31, 2024 | -11.72 Mn |